HIGHLAND CAPITAL MANAGEMENT LP - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 180 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.7%.

Quarter-by-quarter ownership
HIGHLAND CAPITAL MANAGEMENT LP ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$24,343,000
-2.2%
823,791
+57.2%
1.42%
-8.2%
Q1 2019$24,895,000
+98.4%
524,091
+50.7%
1.55%
+61.1%
Q4 2018$12,551,000
+12.7%
347,691
+92.1%
0.96%
+56.6%
Q3 2018$11,140,000
+52.7%
180,991
+67.6%
0.62%
+48.6%
Q2 2018$7,296,000
-17.6%
108,000
-33.9%
0.41%
-9.2%
Q1 2018$8,859,000
+420.8%
163,300
+366.6%
0.46%
+508.0%
Q3 2017$1,701,000
-18.5%
35,000
-23.9%
0.08%
-29.2%
Q1 2017$2,086,00046,0000.11%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders